NRAS and lymphoma: Here, we show that neuropathy of the HSPC niche emerges in two additional experimental models of hematological disease including pre-leukemic myelopoiesis driven by NRAS<sup>G12D</sup> and lymphoma/lymphoblastic leukemia driven by p53 deletion.